Arcadia Biosciences, Inc. (RKDA) stock
RKDANasdaqBeveragesFiscal year ends December 31
$0.19−0.00 (-2.01%)
Close on Nov 17, 2026Market cap $457.03KP/E –Yield –
Arcadia Biosciences r&d expenses
Research and development expenses are spending on new products and technology.
Arcadia Biosciences's R&D Expenses for the twelve months ending Dec 31, 2025 was $9.00K, down 83.0% year over year. For fiscal 2025 it was $9.00K, down 83.0% from the year before. Over ten years it grew -49.9% a year on average. The highest annual figure on record is $10.01M in fiscal 2014.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.00K | -83.0% |
| FY2024 | Dec 31, 2024 | $53.00K | -17.2% |
| FY2023 | Dec 31, 2023 | $64.00K | -95.8% |
| FY2022 | Dec 31, 2022 | $1.51M | -61.2% |
| FY2021 | Dec 31, 2021 | $3.89M | -51.1% |
| FY2020 | Dec 31, 2020 | $7.96M | +12.1% |
| FY2019 | Dec 31, 2019 | $7.10M | +17.0% |
| FY2018 | Dec 31, 2018 | $6.07M | -18.1% |
| FY2017 | Dec 31, 2017 | $7.41M | -14.5% |
| FY2016 | Dec 31, 2016 | $8.66M | -3.4% |
| FY2015 | Dec 31, 2015 | $8.97M | -10.4% |
| FY2014 | Dec 31, 2014 | $10.01M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $0 | – |
| Q4 FY2025 | Dec 31, 2025 | $0 | -100.0% |
| Q3 FY2025 | Sep 30, 2025 | $0 | -100.0% |
| Q2 FY2025 | Jun 30, 2025 | $9.00K | -10.0% |
| Q1 FY2025 | Mar 31, 2025 | $0 | -100.0% |
| Q4 FY2024 | Dec 31, 2024 | $13.00K | +44.4% |
| Q3 FY2024 | Sep 30, 2024 | $24.00K | +60.0% |
| Q2 FY2024 | Jun 30, 2024 | $10.00K | -63.0% |
| Q1 FY2024 | Mar 31, 2024 | $6.00K | -98.3% |
| Q4 FY2023 | Dec 31, 2023 | $9.00K | -98.2% |
| Q3 FY2023 | Sep 30, 2023 | $15.00K | -94.1% |
| Q2 FY2023 | Jun 30, 2023 | $27.00K | -92.5% |
| Q1 FY2023 | Mar 31, 2023 | $359.00K | -9.1% |
| Q4 FY2022 | Dec 31, 2022 | $500.00K | -10.9% |
| Q3 FY2022 | Sep 30, 2022 | $255.00K | -75.4% |
| Q2 FY2022 | Jun 30, 2022 | $359.00K | -68.3% |
| Q1 FY2022 | Mar 31, 2022 | $395.00K | -65.9% |
| Q4 FY2021 | Dec 31, 2021 | $561.00K | -71.4% |
| Q3 FY2021 | Sep 30, 2021 | $1.04M | -41.1% |
| Q2 FY2021 | Jun 30, 2021 | $1.13M | -43.3% |
| Q1 FY2021 | Mar 31, 2021 | $1.16M | -48.4% |
| Q4 FY2020 | Dec 31, 2020 | $1.96M | +14.6% |
| Q3 FY2020 | Sep 30, 2020 | $1.76M | -8.8% |
| Q2 FY2020 | Jun 30, 2020 | $1.99M | +2.2% |
| Q1 FY2020 | Mar 31, 2020 | $2.24M | +49.1% |
| Q4 FY2019 | Dec 31, 2019 | $1.71M | +10.7% |
| Q3 FY2019 | Sep 30, 2019 | $1.93M | +44.8% |
| Q2 FY2019 | Jun 30, 2019 | $1.95M | +8.7% |
| Q1 FY2019 | Mar 31, 2019 | $1.51M | +7.8% |
| Q4 FY2018 | Dec 31, 2018 | $1.55M | -28.7% |
| Q3 FY2018 | Sep 30, 2018 | $1.33M | -23.7% |
| Q2 FY2018 | Jun 30, 2018 | $1.79M | +7.5% |
| Q1 FY2018 | Mar 31, 2018 | $1.40M | -23.4% |
| Q4 FY2017 | Dec 31, 2017 | $2.17M | +8.8% |
| Q3 FY2017 | Sep 30, 2017 | $1.75M | -22.4% |
| Q2 FY2017 | Jun 30, 2017 | $1.67M | – |
| Q1 FY2017 | Mar 31, 2017 | $1.82M | – |
| Q4 FY2016 | Dec 31, 2016 | $1.99M | – |
| Q3 FY2016 | Sep 30, 2016 | $2.26M | – |
See a number that looks wrong?